Retrospective Analysis of T2DM Prescribing Trends in the US from 1996 to 2012
Location
Georgia
Start Date
16-5-2017 1:00 PM
Description
Background: Prevalence of diabetes has more than doubled between 1990 and 2012 in adults age 20 to 79 in the United States, 3.5 to 8.3%. This growing concern of diabetes over the last two decades in both youth and adults has brought about a variety of novel treatment options.
Objective: The primary objective of this study was to determine if prescribing patterns reflected guideline recommendations with regards to pharmacologic and non-pharmacologic treatment of diabetes. In addition to a comparison of guidelines, a secondary objective was to determine any other factors that have influenced prescribing trends over the last two decades.
Methods: Ambulatory care visit data from 1996 to 2012 was extracted from the NAMCS and NHAMCS using T2DM diagnosis codes. Medication was sorted into categories including oral, insulin and insulin analogs, non-pharmacological treatment (diet, exercise). Trends were identified for different age groups (10-17, 18-39, 39+) from 1996-2012.
Results: Among 10-17 year-olds, insulin use increased (8221 to 144809) and use of medication with non-pharmacologic therapy decreased (239606 to 109572). Among 18-39 year-olds, increase in oral medication use (558871 to 1410509) and an increase in multiple medication use (5580 to 264246). Among those 39 and older, there was an increase in insulin use, oral medication use, non-pharmacologic therapy, and multiple medication use.
Discussion: Prescribing of non-pharmacologic therapy remained steady among 10 - 39 year-olds while increasing among those above age 39. Prescribing of insulin saw an increase in those 10-17 and above 39. Oral agent use remained steady among youth while increasing for those over 18. Use of diet and exercise is a mainstay of treatment and with the increase in prevalence, use should have increased among all age groups. Providers should aim to involve patients in their treatment through diet, exercise, and education before use of pharmacologic therapy.
Embargo Period
6-26-2017
Retrospective Analysis of T2DM Prescribing Trends in the US from 1996 to 2012
Georgia
Background: Prevalence of diabetes has more than doubled between 1990 and 2012 in adults age 20 to 79 in the United States, 3.5 to 8.3%. This growing concern of diabetes over the last two decades in both youth and adults has brought about a variety of novel treatment options.
Objective: The primary objective of this study was to determine if prescribing patterns reflected guideline recommendations with regards to pharmacologic and non-pharmacologic treatment of diabetes. In addition to a comparison of guidelines, a secondary objective was to determine any other factors that have influenced prescribing trends over the last two decades.
Methods: Ambulatory care visit data from 1996 to 2012 was extracted from the NAMCS and NHAMCS using T2DM diagnosis codes. Medication was sorted into categories including oral, insulin and insulin analogs, non-pharmacological treatment (diet, exercise). Trends were identified for different age groups (10-17, 18-39, 39+) from 1996-2012.
Results: Among 10-17 year-olds, insulin use increased (8221 to 144809) and use of medication with non-pharmacologic therapy decreased (239606 to 109572). Among 18-39 year-olds, increase in oral medication use (558871 to 1410509) and an increase in multiple medication use (5580 to 264246). Among those 39 and older, there was an increase in insulin use, oral medication use, non-pharmacologic therapy, and multiple medication use.
Discussion: Prescribing of non-pharmacologic therapy remained steady among 10 - 39 year-olds while increasing among those above age 39. Prescribing of insulin saw an increase in those 10-17 and above 39. Oral agent use remained steady among youth while increasing for those over 18. Use of diet and exercise is a mainstay of treatment and with the increase in prevalence, use should have increased among all age groups. Providers should aim to involve patients in their treatment through diet, exercise, and education before use of pharmacologic therapy.